Background: There has been a global increase in the prevalence of obesity in pregnant women in recent years. Animal studies have shown that intrauterine environment associated with maternal obesity leads to epigenetic changes. However, the effects of epigenetic changes occurring before birth in response to maternal conditions have not been clearly characterized in humans. Objective: The aim of the study was to analyze peroxisome proliferator-activated receptor (PPAR)-γ expression in cell cultures from newborns from mothers with overweight and obesity, in response to in vitro metabolic challenges and their relationship with microRNA profile and cytokine expression. Methods/Study design: The profile of circulating microRNAs from 72 mother-child pairs (including healthy infants born to normal weight [n = 35], overweight [n = 25], and obese [n = 12] mothers) was determined through real-time PCR, and the PPAR-γ expression in peripheral blood mononuclear cell cultures from offspring was analyzed after in vitro challenges. Results: miR-146a, miR-155, and miR-378a were upregulated in overweight mothers, while miR-378a was upregulated in obese mothers compared to normal weight mothers. In children from overweight mothers, miR-155 and miR-221 were downregulated and miR-146a was upregulated, while offspring of mothers with obesity showed downregulation of miR-155, miR-221, and miR-1301. These microRNAs have direct or indirect relation with PPAR-γ expression. In vitro exposure to high triglyceride and exposure to miR-378a induced a higher expression of PPAR-γ in cells from offspring of mothers with overweight and obesity. In contrast, cells from offspring of mothers with obesity cultured with high glucose concentrations showed PPAR-γ downregulation. IL-1ß, IL-6, and TNF-α expression in cells of offspring of overweight and obese mothers differed from that of offspring of normal weight mothers. Limitation of our study is the small sample size. Conclusion: The blood microRNA profile, and in vitro PPAR-γ and inflammatory cytokine expression in cells of newborn infants are associated with maternal obesity indicating that epigenetic marks may be established during intrauterine development. Key Message: Neonatal microRNA profile is associated with maternal weight. Neonatal microRNA profile is independent of maternal microRNA profile. PPAR-γ expression in newborn cell cultures is affected by maternal weight

1.
World Health Organization
.
Obesity and overweight
.
Geneva
:
World Health Organization
;
2020
. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed 2021 Feb 14).
2.
Pereira
TJ
,
Moyce
BL
,
Kereliuk
SM
,
Dolinsky
VW
.
Influence of maternal overnutrition and gestational diabetes on the programming of metabolic health outcomes in the offspring: experimental evidence
.
Biochem Cell Biol
.
2014
;
93
:
438
51
. .
3.
Damm
P
,
Houshmand-Oeregaard
A
,
Kelstrup
L
,
Lauenborg
J
,
Mathiesen
ER
,
Clausen
TD
.
Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark
.
Diabetologia
.
2016
;
59
:
1396
9
. .
4.
Godfrey
KM
,
Gluckman
PD
,
Hanson
MA
.
Developmental origins of metabolic disease: life course and intergenerational perspectives
.
Trends Endocrinol Metab
.
2010
;
21
:
199
205
. .
5.
Lewis
RM
,
Desoye
G
.
Placental lipid and fatty acid transfer in maternal overnutrition
.
Ann Nutr Metab
.
2017
;
70
(
3
):
228
31
. .
6.
Borengasser
SJ
,
Zhong
Y
,
Kang
P
,
Lauenborg
J
,
Mathiesen
ER
,
Clausen
TD
.
Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark
.
Endocrinology
.
2013
;
154
:
4113
25
.
7.
Neri
C
,
Edlow
A
.
Effects of maternal obesity on fetal programming: molecular approaches
.
Cold Spring Harb Perspect Med
.
2016
;
6
:
1
21
.
8.
Zaiou
M
,
El Amri
H
,
Bakillah
A
.
The clinical potential of adipogenesis and obesity-related microRNAs
.
Nutr Metab Cardiovasc Dis
.
2018
;
28
:
91
111
. .
9.
Balasubramanyam
M
,
Aravind
S
,
Gokulakrishnan
K
,
Prabu
P
,
Sathishkumar
C
,
Ranjani
H
,
Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes
.
Mol Cell Biochem
.
2011
;
351
:
197
205
. .
10.
Ishida
M
,
Shimabukuro
M
,
Yagi
S
,
Nishimoto
S
,
Kozuka
C
,
Fukuda
D
,
MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism
.
PLoS One
.
2014
;
9
:
e111537
. .
11.
Weedon-Fekjær
MS
,
Sheng
Y
,
Sugulle
M
,
Johnsen
GM
,
Herse
F
,
Redman
CW
,
Placental miR-1301 is dysregulated in early-onset preeclampsia and inversely correlated with maternal circulating leptin
.
Placenta
.
2014
;
35
(
9
):
709
17
. .
12.
Nardelli
C
,
Iaffaldano
L
,
Ferrigno
M
,
Labruna
G
,
Maruotti
GM
,
Quaglia
F
,
Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women
.
Int J Obes
.
2014
;
38
:
466
9
. .
13.
Méndez-Mancilla
A
,
Lima-Rogel
V
,
Toro-Ortíz
JC
,
Escalante-Padrón
F
,
Monsiváis-Urenda
AE
,
Noyola
DE
,
Differential expression profiles of circulating microRNAs in newborns associated to maternal pregestational overweight and obesity
.
Pediatr Obes
.
2018
;
13
:
168
74
. .
14.
Feige
JN
,
Gelman
L
,
Michalik
L
,
Desvergne
B
,
Wahli
W
.
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
.
Prog Lipid Res
.
2006
;
45
:
120
59
. .
15.
Leftherova
MI
,
Haakonsson
AK
,
Lazar
MA
,
Mandrup
S
.
PPARg and the global map of adipogenesis and beyond
.
Trends Endocrinol Metab
.
2014
;
25
:
293
302
.
16.
Abranches
MV
,
De Oliveira
FCE
,
Bressan
J
.
Receptores activados por los proliferadores de peroxisomas: implicaciones sobre la homeostasis nutricional, en la obesidad y en la diabetes mellitus
.
Nutr Hosp
.
2011
;
26
:
271
9
.
17.
Kadam
L
,
Kohan-Ghadr
HR
,
Drewlo
S
.
The balancing act: PPAR-γ’s roles at the maternal-fetal interface
.
Syst Biol Reprod Med
.
2015
;
61
:
65
71
. .
18.
Gao
Y
,
She
R
,
Sha
W
.
Gestational diabetes mellitus is associated with decreased adipose and placenta peroxisome proliferator-activator receptor γ expression in a Chinese population
.
Oncotarget
.
2017
;
8
:
113928
37
. .
19.
Boyle
KE
,
Patinkin
ZW
,
Shapiro
AL
,
Baker
PR
,
Dabelea
D
,
Friedman
JE
.
Mesenchymal stem cells from infants born to obese mothers exhibit greater potential for adipogenesis: the healthy start babybump project
.
Diabetes
.
2016
;
65
:
647
59
. .
20.
Heidarzadeh
Z
,
Samimi
M
,
Seifati
SM
,
Ashkezari
MD
,
Ahmadi
S
,
Mahmoodi
S
,
The effect of zinc supplementation on expressed levels of peroxisome proliferator-activated receptor gamma and glucose transporter type 1 genes in newborns of women with gestational diabetes mellitus
.
Biol Trace Elem Res
.
2017
;
175
(
2
):
271
7
. .
21.
Yu
Y
,
Du
H
,
Wei
S
,
Feng
L
,
Li
J
,
Yao
F
,
Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARγ
.
Theranostics
.
2018
;
8
:
2171
88
. .
22.
Omidi
Y
,
Hollins
AJ
,
Benboubetra
M
,
Drayton
R
,
Benter
IF
,
Akhtar
S
.
Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells
.
J Drug Target
.
2003
;
11
:
311
23
. .
23.
Huang
Q
,
Ma
C
,
Chen
L
,
Luo
D
,
Chen
R
,
Liang
F
.
Mechanistic insights into the interaction between transcription factors and epigenetic modifications and the contribution to the development of obesity
.
Front Endocrinol
.
2018
;
9
:
370
. .
24.
Liang
YZ
,
Dong
J
,
Zhang
J
,
Wang
S
,
He
Y
,
Yan
YX
.
Identification of neuroendocrine stress response-related circulating MicroRNAs as biomarkers for type 2 diabetes mellitus and insulin resistance
.
Front Endocrinol
.
2018
;
9
:
1
11
.
25.
Bala
S
,
Csak
T
,
Saha
B
,
Zatsiorsky
J
,
Kodys
K
,
Catalano
D
,
The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis
.
J Hepatol
.
2016
;
64
:
1378
87
. .
26.
Liang
H
,
Ward
WF
.
PGC-1a: a key regulator of energy metabolism
.
Adv Physiol Educ
.
2006
;
63
:
145
51
.
27.
Neetu
S
,
Hanyuan
Z
,
Kaichao
P
,
Xiao
C
,
Juan
C
,
Qiaozhu
S
.
Aberrant expression of microRNA induced by high fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance
.
J Nutr Biochem
.
2017
;
43
:
125
31
.
28.
Kim
J
,
Hyun
J
,
Wang
S
,
Lee
C
,
Jung
Y
.
MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver
.
Cell Death Dis
.
2018
;
9
:
721
. .
29.
Wankhade
UD
,
Zhong
Y
,
Kang
P
,
Alfaro
M
,
Chintapalli
SV
,
Piccolo
BD
,
Maternal high-fat diet programs offspring liver steatosis in a sexually dimorphic manner in association with changes in gut microbial ecology in mice
.
Sci Rep
.
2018
;
8
:
16502
. .
30.
Melekoglu
R
,
Ciftci
O
,
Eraslan
S
,
Basak
N
,
Celik
E
.
The effects of body mass index on second-trimester amniotic fluid cytokine and matrix metalloproteinase levels
.
Gynecol Obstet Invest
.
2018
;
83
(
1
):
70
5
. .
31.
McCullough
LE
,
Miller
EE
,
Calderwood
LE
,
Shivappa
N
,
Steck
SE
,
Forman
MR
,
Maternal inflammatory diet and adverse pregnancy outcomes: circulating cytokines and genomic imprinting as potential regulators?
Epigenetics
.
2017
;
12
:
688
97
. .
32.
Sharma
S
,
Eghbali
M
.
Influence of sex differences on microRNA gene regulation in disease
.
Biol Sex Differ
.
2014
;
5
:
3
. .
33.
Sedlmeier
EM
,
Meyer
DM
,
Stecher
L
,
Sailer
M
,
Daniel
H
,
Hauner
H
,
Fetal sex modulates placental microRNA expression, potential microRNA-mRNA interactions, and levels of amino acid transporter expression and substrates: INFAT study subpopulation analysis of n-3 LCPUFA intervention during pregnancy and associations with offspring body composition
.
BMC Mol Cell Biol
.
2021
;
22
(
1
):
15
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.